Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised the arranging banks in connection with Svenska Handelsbanken’s issue of Convertible Additional Tier 1 Capital in the amount of MUSD 500
Mandate

Vinge has advised the arranging banks in connection with Svenska Handelsbanken’s issue of Convertible Additional Tier 1 Capital in the amount of MUSD 500

February 19, 2019 Banking and Finance

Vinge has advised Morgan Stanley & Co. International plc and the other arranging banks consisting of Citigroup Global Markets Limited, Deutsche Bank AG, London Branch, Svenska Handelsbanken AB (publ) and UBS Limited in respect of Swedish law in connection with Svenska Handelsbanken’s issue of Additional Tier 1 bonds in the amount of approximately MUSD 500.

The bonds are perpetual instruments without a final maturity date, without the right of premature redemption during the first five years and with an automatic conversion to class A shares in the event that the bank’s core equity capital falls below a certain level. 

The issue will strengthen the bank’s core equity capital by 0.6 points. The issue will be subscribed and allocated to the arranging banks on 22 February 2019. 

The bonds will be listed on Euronext Dublin. 

Vinge’s team consisted of Mikael Ståhl, Josefine Larsson, Malte Hedlund and Paulina Malmberg.
 

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

 Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

 HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

 Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026